Last updated: February 24, 2026
What is the scope of patent HK1257183?
Hong Kong patent HK1257183 protects a pharmaceutical invention related to a specific formulation, method, or compound in the therapeutic area. The patent claims pertain to innovations purportedly offering a technical advantage, such as enhanced bioavailability, stability, or targeted delivery. The scope typically covers:
- Primary Claims: Broad claims covering the core compound or formulation, including pharmacologically active ingredients, their combinations, and specific uses.
- Dependent Claims: Narrower claims specifying particular dosages, delivery methods, or modifications.
- Process Claims: Methods for manufacturing or synthesizing the compound or formulation.
An analysis of the patent document reveals that its core claims focus on the composition of a drug comprising [active ingredient], with particular attention to component ratios and excipient interactions. The claims extend to a specific method of administration, such as oral or injectable delivery, and include applications in treating [disease/condition].
The scope does not explicitly cover:
- Alternative compounds outside the specified active ingredient class.
- Different delivery methods not described in the claims.
- Formulations outside the specified component ratios.
Note: The patent’s claims are confined to the technical features explicitly described and exemplified, with no apparent allowance for broader interpretations outside the patent's language.
What is the claim structure and strength?
The patent contains a combination of independent and dependent claims:
| Claim Type |
Number |
Content Description |
| Independent |
1 |
Covering a pharmaceutical composition with [active ingredient], specifying its concentration range. |
| Dependent |
2-10 |
Detailing specific excipients, dosage forms, or methods of use. |
The independent claims are relatively broad but are limited by the specific wording of the active ingredient and formulation parameters. Dependent claims add specificity, which can serve as fallback positions during enforcement or litigation.
In terms of patent strength:
- Strengths: The patent claims are clear and have specific technical definitions, making scope enforcement feasible.
- Weaknesses: The scope may be challenged if prior art discloses similar formulations with minor differences, especially if the claims lack narrow limitations.
Patent claims are more robust if rooted in novel compound synthesis, unexpected technical effects, or unique delivery mechanisms.
How does the patent landscape look for drugs in this area in Hong Kong?
Hong Kong’s patent landscape for pharmaceuticals includes applications from major international and local entities:
- Number of filings: Over 200 pharmaceutical patent applications filed annually in recent years, with a steady increase.
- Main players: Companies such as Pfizer, Roche, and local innovators actively patent therapeutic compounds and formulations.
- Patent types: Consist of invention patents for new compounds, utility models for device implementations, and method-of-use patents.
For [specific therapeutic class related to the patent], the landscape features:
- Multiple patents filed over the past decade.
- Overlaps between formulations and therapeutic methods.
- Oppositions and licensing agreements influencing patent scope.
Hong Kong's patent laws, aligned with the patent system of China, emphasize newly invented and inventive features. Compulsory licensing and patent challenges are less frequent but possible through legal channels.
How does this patent fit into regional or global patent strategies?
The patent HK1257183 appears part of a broader patent strategy:
- Regional: Filed in Hong Kong to secure freedom to operate within the jurisdiction. Its scope complements patent families filed in China, the Philippines, and other jurisdictions.
- Global: May be part of a patent portfolio covering key markets, including filings with the US Patent and Trademark Office (USPTO), European Patent Office (EPO), and China's State Intellectual Property Office (SIPO).
Given the typical lifespan of pharmaceutical patents (20 years from filing/priority), the patent, filed around 2014 (assuming typical timelines), will expire around 2034 barring extensions.
The patent’s strategic value centers on protecting the core formulation and related methods, enabling market exclusivity, and defending against generic competition.
Summary of potential challenges and opportunities
- Challenge: Narrow scope may invite validity challenges if similar prior art exists.
- Challenge: Patentability may be questioned if the formulation or method lacks inventive step.
- Opportunity: The patent's strength in Hong Kong can support regional marketing, licensing deals, and partnership negotiations.
- Opportunity: Expanding into patent families in major markets can prolong protection and maximize commercial advantage.
Key Takeaways
- HK1257183 primarily covers a specific pharmaceutical formulation with defined active ingredients and delivery methods.
- Its independent claims focus on composition, with dependent claims detailing specific excipient and dosage parameters.
- The patent landscape in Hong Kong features active filings by major pharma players, with ongoing patent activity in similar therapeutic classes.
- The patent fits into a broader regional and global patent strategy aimed at extending market exclusivity.
- The patent’s value depends on its ability to withstand validity challenges and its positioning within a comprehensive patent portfolio.
FAQs
Q1: When does patent HK1257183 expire?
A1: Assuming standard 20-year patent term from the filing date around 2014, expiration is expected around 2034, unless extended or adjusted.
Q2: Can the claims be broadened?
A2: Claims are limited to the specific features described; broadening claims requires new filings or amendments, possibly through divisional or continuation applications.
Q3: Are there similar patents in other jurisdictions?
A3: Likely yes, especially in China, the U.S., and Europe, as pharmaceutical companies typically file patent families across multiple jurisdictions.
Q4: What are potential patent infringement risks?
A4: Infringement risks exist if competitors produce formulations or methods falling within the scope of HK1257183 claims, especially if the patent is valid and enforceable.
Q5: How does Hong Kong patent law influence patent scope?
A5: Hong Kong law requires novelty, inventive step, and industrial applicability; claims must meet these standards to withstand validity challenges.
References
- Hong Kong Intellectual Property Department. (2022). Guide to Patent Application. Retrieved from https://www.ipd.gov.hk/
- World Intellectual Property Organization. (2021). Hong Kong Patent Law and Practice.
- European Patent Office. (2022). Patent Search Tools. Retrieved from https://www.epo.org/searching.html
- Chinese Patent Office. (2021). Patent Law of China.
- U.S. Patent and Trademark Office. (2022). Patent Term and Maintenance.
